These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14004619)

  • 21. [On the problem of the nature of a fibrinolytic substance in plague microbes].
    IAROMIUK GA; DOMARADSKII IV
    Biull Eksp Biol Med; 1962 Apr; 53():87-91. PubMed ID: 14450449
    [No Abstract]   [Full Text] [Related]  

  • 22. Pasteurella pestis of low virulence for mice and guinea pigs isolated from a Peromyscus plague focus in Utah.
    MARCHETTE NJ
    Am J Trop Med Hyg; 1963 Mar; 12():215-8. PubMed ID: 13932840
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
    Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J
    Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [EFFECT OF IRON ON THE VIRULENCE AND IMMUNOGENICITY OF AVIRULENT STRAINS OF THE PLAGUE PATHOGEN].
    AVANLAN Ia; GUBINA NE; IVANOVA VF
    Zh Mikrobiol Epidemiol Immunobiol; 1963 May; 40():17-23. PubMed ID: 14077135
    [No Abstract]   [Full Text] [Related]  

  • 25. The immune response of the guinea pig to the antigens of Pasteurella pestis.
    SPIVACK ML; FOSTER L; LARSON A; CHEN TH; BAKER EE; MEYER KF
    J Immunol; 1958 Feb; 80(2):132-41. PubMed ID: 13514082
    [No Abstract]   [Full Text] [Related]  

  • 26. Response of guinea pig lungs to in vivo and in vitro cultures of Pasteurella pestis.
    FUKUI GM; LAWTON WD; JANSSEN WA; SURGALLA MJ
    J Infect Dis; 1957; 100(1):103-7. PubMed ID: 13416642
    [No Abstract]   [Full Text] [Related]  

  • 27. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
    Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
    Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
    Glynn A; Roy CJ; Powell BS; Adamovicz JJ; Freytag LC; Clements JD
    Infect Immun; 2005 Aug; 73(8):5256-61. PubMed ID: 16041052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the capsule of Pasteurella pestis in bubonic plague in the guinea pig.
    DONAVAN JE; HAM D; FUKUI GM; SURGALLA MJ
    J Infect Dis; 1961; 109():154-7. PubMed ID: 13887192
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on immunization against plague. VI. Growth of pasteurella pestis and the production of the envelope and other soluble antigens in a casein hydrolyzate mineral glucose medium.
    ENGELSBERG E; LEVY JB
    J Bacteriol; 1954 Apr; 67(4):438-49. PubMed ID: 13152055
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of streptomycin therapy on the pathogenic action of Pasteurella pestis in experimentally induced pneumonic plague in guinea pigs].
    NEEL R
    Bull Soc Pathol Exot Filiales; 1951; 44(1-2):69-76. PubMed ID: 14830980
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on immunization against plague. XV. The pathophysiologic action of the toxin of Pasteurella pestis in experimental animals.
    SCHAR M; MEYER KF
    Schweiz Z Pathol Bakteriol; 1956; 19(1):51-70. PubMed ID: 13337305
    [No Abstract]   [Full Text] [Related]  

  • 33. Structural features and structural variability of the lipopolysaccharide of Yersinia pestis, the cause of plague.
    Knirel YA; Dentovskaya SV; Senchenkova SN; Shaikhutdinova RZ; Kocharova NA; Anisimov AP
    J Endotoxin Res; 2006; 12(1):3-9. PubMed ID: 16420739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [ON COAGULATION OF BLOOD PLASMA BY PLAGUE AND PSEUDOTUBERCULOSIS MICROBES].
    DOMARADSKII IV; IAROMIUK GA; VASIUKHINA LV; KOROTAEVA AV
    Biull Eksp Biol Med; 1963 Jul; 56():79-82. PubMed ID: 14068613
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of the antiserum-agar plate technique for specific identification and isolation of Pasteurella pestis.
    Albizo JM; Surgalla MJ
    Appl Microbiol; 1968 Aug; 16(8):1114-9. PubMed ID: 4877497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small protective fragments of the Yersinia pestis V antigen.
    Vernazza C; Lingard B; Flick-Smith HC; Baillie LW; Hill J; Atkins HS
    Vaccine; 2009 May; 27(21):2775-80. PubMed ID: 19366573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen.
    Garmory HS; Freeman D; Brown KA; Titball RW
    Vaccine; 2004 Feb; 22(8):947-57. PubMed ID: 15161071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional profiling of a mice plague model: insights into interaction between Yersinia pestis and its host.
    Liu H; Wang H; Qiu J; Wang X; Guo Z; Qiu Y; Zhou D; Han Y; Du Z; Li C; Song Y; Yang R
    J Basic Microbiol; 2009 Feb; 49(1):92-9. PubMed ID: 18759226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional responses in spleens from mice exposed to Yersinia pestis CO92.
    Rogers JV; Choi YW; Giannunzio LF; Sabourin PJ; Bornman DM; Blosser EG; Sabourin CL
    Microb Pathog; 2007; 43(2-3):67-77. PubMed ID: 17531433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague.
    Elvin SJ; Williamson ED
    Microb Pathog; 2004 Oct; 37(4):177-84. PubMed ID: 15458778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.